Edoxaban: Considerable added benefit for certain patients

Edoxaban (trade name: Lixiana) has been approved since June 2015 for two therapeutic indications in adults: on the one hand, for prevention of stroke and systemic embolism in adults with non-valvular atrial fibrillation (NVAF) ...

Diseases, Conditions, Syndromes

Review supports LMWH for cancer-linked incidental PE

(HealthDay)—Cancer-associated incidental pulmonary embolism (IPE) should be treated with low molecular weight heparins (LMWHs), according to a review published online Oct. 15 in the Journal of Thrombosis and Haemostasis.


Catheter-directed, low-dose fibrinolysis safe, effective for PE

(HealthDay)—Ultrasound-facilitated, catheter-directed, low-dose fibrinolysis appears safe and efficacious for acute massive and submassive pulmonary embolism (PE), according to a study published in the Aug. 24 issue of ...


Channel length key in percutaneous thrombin injection

(HealthDay)—About 15 percent of patients with post-catheterization femoral pseudoaneurysm who undergo sonographic-guided percutaneous thrombin injection have complications, mainly arterial microembolization, according to ...

page 4 from 17